Articles tagged with Eye Cancers
The collaboration between ophthalmology and facial plastic surgery has led to fresh approaches in clinical problems, exemplified by well-designed clinical studies. Articles in this issue of Archives of Ophthalmology showcase new technology and precise measurements during eyelid surgery.
A molecular pathway that plays a critical role in blood vessel growth has been identified by researchers. The finding suggests a potential target for inhibiting the growth of blood vessels that fuel cancers, diabetic eye complications, and atherosclerosis. The study used zebrafish as a model organism to discover the pathway.
A study found that individuals with suppressed immune systems, such as kidney transplant patients and those with HIV, have a higher incidence of squamous cell eye cancer. Residence in subtropical regions and prior history of skin cancer were also associated with increased risk.
A new procedure at UCLA's Jules Stein Eye Institute uses fine-needle aspiration to collect cancer cells from the living eye and predict high-risk tumors. The test has shown promise in reducing mortality rates among ocular melanoma patients.
New data from ECCO suggests a strong correlation between Chlamydia psittaci infection and development of ocular adnexal lymphoma (OAL), with C. psittaci found in 78% of all OAL cases but only 23% of non-cancerous disease cases.
Researchers discovered that Arf gene restricts blood vessel growth in the eye during embryonic development, preventing excessive growth and associated cancers. This finding may lead to new therapies for persistent hyperplastic primary vitreous and anticancer drugs.
Patients with massive skin cancers can now experience significant improvement in function, appearance, and quality of life after undergoing free tissue transfer surgery. This innovative technique, pioneered by OHSU researchers, has revolutionized the care of patients with this condition.
Researchers found that survival rates for primary eye cancer treatments are essentially the same, with a five-year survival rate of 82% for both radiation therapy and eye removal. The study's findings expand the capability of doctors to provide accurate diagnoses and state-of-the-art treatments.
A recent study by Ohio State University found that survival rates are similar for patients with choroidal melanoma who undergo radiation therapy or have their affected eye removed. The study, which involved 1,317 patients, showed that both treatment options result in high five-year survival rates.
Researchers at the University of Alberta created an artificial eye that can rotate in synchronicity with its 'good partner', using a tiny electrical motor and infrared detectors. The implant aims to alleviate psychological and physical symptoms associated with missing eyes, giving patients more confidence after radical facial surgery.
Researchers at the Mayo Clinic found that an experimental diode laser treatment controlled cancer growth in all but one patient with melanoma in the eye. No recurrences were noted in the remaining patients during follow-up periods.
University of Iowa researchers have shed light on the mysteries of metastasis by studying uveal melanoma, a potentially blinding and fatal form of cancer. They found that abnormal proteins respond to hepatocyte growth factor/scatter factor, attracting blood vessels and causing cancer cells to spread.
Researchers found that combining ganciclovir eye implants with oral ganciclovir reduces the risk of new CMV disease, Kaposi's sarcoma, and extraocular complications in AIDS patients. The study also showed a delay in median survival time among those receiving combined therapy.